Aetna (AET) is expected to report Q1 earnings before the market open on Thursday, April 26 with a conference call scheduled for 8:30am ET.
Analysts are looking for EPS of $1.39 on revenue of $8.68B. The consensus range is $1.18-$1.48 for EPS, and $8.93B-$9.06B for revenue, according to First Call. Positives catalysts for the insurer should be seen coming from Medicare Advantage enrollments. Negatives for this quarter will most likely be seen coming from increases in medical costs, as seen in what Aetna competitors WellPoint (WLP) and UnitedHealth group (UNH) both said in their recent earnings reports.
On April 23, Susquehanna said Medicare Advantage guidelines were a positive for group. On March 23, Goldman Sachs downgraded Aetna to to Neutral from Buy citing limited growth in its commercial health plan business. The firm placed a $54 price target on shares.